DWDaniëlle C. M. Willems

Daniëlle C. M. Willems

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniëlle C. M. Willems has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders

    by Daniëlle C. M. Willems, Manuela A. Joore, Fred H. M. Nieman, Johan L. Severens, Emiel F. M. Wouters, Johannes J. E. Hendriks

    Objectives: This study explores several variables of the EQ-5D child version, a multi-attribute utility instrument, in children with chronic conditions. Methods: A convenience sample was selected from hospital outpatient records and school records. The sample included children aged 7–18 years with the following chronic conditions: asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders. The practicality, convergent validity, and discriminant power were compared with a generic quality of life questionnaire for children (TACQOL) and the 2-week test–retest reliability was assessed. Results: A total of 182 children or their parents completed the first questionnaire and 161 children/parents completed both questionnaires. The practicality of the EQ-5D was good. Low to moderate correlations were found between the utilities and VAS scores and the TACQOL scales. The discriminant power of the EQ-5D items was low overall and was greater for children with a rheumatic disorder than for children with the other conditions. In the subset of children who experienced no health change between the test and the retest, the reliability of the EQ-5D was moderate to high. Conclusions: The EQ-5D seems suitable for children, although the use of an additional disease-specific questionnaire is still recommended. The EQ-5D seems the most suitable for children with a chronic physical condition and appears to be reliable for children with a stable health status.


  • The effectiveness of nurse‐led telemonitoring of asthma: results of a randomized controlled trial

    by Daniëlle C. M. Willems, Manuela A. Joore, Johannes J. E. Hendriks, Fred H. M. Nieman, Johan L. Severens, Emiel F. M. Wouters

    Rationale, aims and objectives  The aim of the study was to evaluate the effects on, and the relationship between, asthma symptoms, asthma‐specific quality of life and medical consumption of a nurse‐led telemonitoring intervention compared with regular care in asthma in the Netherlands.Methods  One hundred and nine asthmatic outpatients (56 children; 53 adults) were randomly assigned to the treatment arms (12‐month follow‐up). The control group received regular outpatient care, while the intervention group used an asthma monitor with modem at home with an asthma nurse as the main caregiver. Clinical asthma symptoms and medical consumption were measured by using diaries. Asthma‐specific quality of life was measured by the (Paediatric) Asthma Quality of Life Questionnaire.Results  The study population generally represented mild to moderate asthmatics. The results show improvement in follow‐up, but no statistically significant difference between the groups was observed. Moderate to high correlations were found within the outcome parameters, but the most remarkable was the low and statistically significant correlation between asthma‐specific quality of life (daily functioning) and the self‐reported beta‐2 agonists.Conclusion  Overall, the telemonitoring programme evaluated in this study did not significantly decrease asthma symptoms or medical consumption, or improve asthma‐specific quality of life. The results showed that a telemonitoring programme on its own is not a guarantee of success. The patients' perception of asthma‐specific quality of life (daily functioning) should be a key element in asthma telemonitoring programmes.


  • Open Access

    Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial

    by Daniëlle Cm Willems, Manuela A Joore, Johannes Je Hendriks, Emiel Fm Wouters, Johan L Severens

    Asthma is a chronic lung disease in which recurrent asthma symptoms create a substantial burden to individuals and their families. At the same time the economic burden associated with asthma is considerable.